Pharma news
Americas
In the life sciences sector, defending broad patent claims can be a tricky business, says Gordon Wright. 16 October 2013
Pharma
For generic drug makers, previous bad behaviour may affect new litigation, especially when it comes to injunctions, as Bethan Hopewell and Geraldine Quinn explain. 16 October 2013
Asia
Bayer has appealed against the IPAB’s compulsory licence order that allows domestic generic maker Natco Pharma to market its own version of liver and kidney cancer drug Nexavar, this time at the Mumbai High Court. 15 October 2013
Americas
Andrulis Pharmaceuticals Corp has accused Celgene Corp of infringing and inducing the infringement of one of its patents related to a method of treating cancer. 8 October 2013
Pharma
The annual International Association for the Protection of IP (AIPPI) conference in Helsinki, Finland, assessed the potential problems for pharmaceutical companies trying to brand their medicinal products. 30 September 2013
Americas
India’s drug patent policy has been slammed by US companies who are insisting that action be taken in order to improve trade relations. 30 September 2013
Americas
A federal judge has denied AstraZeneca’s motions to dismiss claims challenging its pay-for-delay deals with three generic pharmaceutical companies in connection to heartburn drug Nexium. 27 September 2013
Pharma
The government in South Africa is considering changing its national policy on IP, a move that could have far reaching effects for its patents system. 26 September 2013
Americas
A US company which provides secure personal medical records online has filed a patent infringement case against a rival health-care company. 26 September 2013
Americas
The US District Court for the District of New Jersey has found in favour of Teva Pharmaceutical Industries Ltd in its patent infringement case with Mylan over Parkinson’s disease drug Azilect. 25 September 2013